Increased cytotoxicity of CD4+ invariant NKT cells against CD4+CD25hiCD127lo/- regulatory T cells in allergic asthma

European Journal of Immunology

Volumn 38, Issue 7, 2008, Pages 2034-2045

  Nguyen, Khoa D ^a   Vanichsarn, Chris ^a   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Granzyme B; Invariant NKT cells; Natural cytotoxicity receptors; Perforin; Regulatory T cells

Indexed keywords

CORTICOSTEROID; GRANZYME B; IMMUNOGLOBULIN E; NATURAL KILLER CELL RECEPTOR; PERFORIN; SALBUTAMOL; SALMETEROL; ANTIASTHMATIC AGENT; GRANZYME; IMMUNOGLOBULIN RECEPTOR; NCR1 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL KILLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LYMPHOCYTOTOXICITY; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STAINING; ASTHMA; CYTOTOXICITY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; T LYMPHOCYTE SUBPOPULATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; HUMANS; MIDDLE AGED; PERFORIN; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 50549092067     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200738082     Document Type: Article

References (46)

1. Sears, M. R., Burrows, B., Flannery, E. M., Herbison, G. P., Hewitt, C. J. and Holdaway, M. D., Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 1991. 325: 1067-1071.
2. Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C. et al., Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992. 326: 298-304.
3. Umetsu, D. T. and Dekruyff, R. H., Immune dysregulation in asthma. Curr. Opin. Immunol. 2006. 18: 727-732.
4. Robinson, D. S., The role of regulatory T lymphocytes in asthma pathogenesis. Curr. Allergy Asthma Rep. 2005. 5: 136-141.
5. + regulatory T cells. Semin. Immunol. 2004. 16: 89-98.
6. Kim, J. M. and Rudensky, A., The role of the transcription factor FoxP3 in the development of regulatory T cells. Immunol. Rev. 2006. 212: 86-98.
7. hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 2007. 119: 1258-1266.
8. Grindebacke, H., Wing, K., Andersson, A. C., Suri-Payer, E., Rak, S. and Rudin, A., Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy 2004. 34: 1364-1372.
9. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004. 363: 608-615.
10. + regulatory T cells is interleukin 10 dependent. J. Exp. Med. 2005. 202: 1539-1547.
11. + regulatory T cells. J. Exp. Med. 2006. 203: 2649-2660.
12. Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G. et al., Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002. 8: 1024-1032.
13. + T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 2005. 202: 1549-1561.
14. Montoya, C. J., Pollard, D., Martinson, J., Kumari, K., Wasserfall, C., Mulder, C. B., Rugeles, M. T. et al., Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007. 122: 1-14.
15. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625-636.
16. Godfrey, D. I. and Kronenberg, M., Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004. 114: 1379-1388.
17. Sullivan, B. A. and Kronenberg, M., Activation or anergy: NKT cells are stunned by alpha-galactosylceramide. J. Clin. Invest. 2005. 115: 2328-2329.
18. Akbari, O., Stock, P., Meyer, E., Kronenberg, M., Sidobre, S., Nakayama, T., Taniguchi, M. et al., Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 2003. 9: 582-588.
19. Lisbonne, M., Diem, S., de Castro Keller, A., Lefort, J., Araujo, L. M., Hachem, P., Fourneau, J. M. et al., Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 2003. 171: 1637-1641.
20. + T cells are dispensable for T cell-dependent allergic airway inflammation. Nat. Med. 2006. 12: 1345-1346.
21. + T cells in asthma: Modulation by allergic status and oral corticosteroids. J. Allergy Clin. Immunol. 2007. 120: 1441-1448.
22. + natural killer T cells in bronchial asthma. N. Engl. J. Med. 2006. 354: 1117-1129.
23. Bratke, K., Julius, P. and Virchow, J. C., Invariant natural killer T cells in obstructive pulmonary diseases. N. Engl. J. Med. 2007. 357: 194.
24. Thomas, S. Y., Lilly, C. M. and Luster, A. D., Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med. 2006. 354: 2613-2616.
25. Vijayanand, P., Seumois, G., Pickard, C., Powell, R. M., Angco, G., Sammut, D., Gadola, S. D. et al., Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 2007. 356: 1410-1422.
26. + Tregs and NKT cells: Regulators regulating regulators. Trends Immunol. 2006. 27: 322-327.
27. + regulatory T cells? Eur. J. Immunol. 2005. 35: 1193-1200.
28. + regulatory T cells suppress NKT cell functions. Cancer Res. 2003. 63: 4516-4520.
29. Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F. and D'Ambrosio, D., Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 2001. 194: 847-853.
30. Inngjerdingen, M., Damaj, B. and Maghazachi, A. A., Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 2000. 164: 4048-4054.
31. De Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S. et al., Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 2007. 37: 445-455.
32. Epling-Burnette, P. K., Bai, F., Painter, J. S., Rollison, D. E., Salih, H. R., Krusch, M., Zou, J. et al., Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood 2007. 109: 4816-4824.
33. Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T. and Spengler, U., Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006. 55: 869-877.
34. Lecoeur, H., de Oliveira-Pinto, L.M. and Gougeon, M. L., Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods 2002. 265: 81-96.
35. Shi, L., Kraut, R. P., Aebersold, R. and Greenberg, A. H., A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 1992. 175: 553-566.
36. Atkinson, E. A., Barry, M., Darmon, A. J., Shostak, I., Turner, P. C., Moyer, R.W. and Bleackley, R. C., Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J. Biol. Chem. 1998. 273: 21261-21266.
37. Grullich, C., McGoldrick, S., Zeiser, R. and Finke, J., The death receptor pathway is not involved in alloreactive T-cell induced mitochondrial membrane permeability. Leuk. Lymphoma 2005. 46: 1207-1216.
38. Lehmann, C., Zeis, M., Schmitz, N. and Uharek, L., Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 2000. 96: 594-600.
39. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. et al., Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001. 19: 197-223.
40. Chiossone, L., Vitale, C., Cottalasso, F., Moretti, S., Azzarone, B., Moretta, L. and Mingari, M. C., Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: Evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 2007. 109: 3767-3775.
41. Mavoungou, E., Bouyou-Akotet, M. K. and Kremsner, P. G., Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin. Exp. Immunol. 2005. 139: 287-296.
42. Vitale, C., Chiossone, L., Cantoni, C., Morreale, G., Cottalasso, F., Moretti, S., Pistorio, A. et al., The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur. J. Immunol. 2004. 34: 3028-3038.
43. Walzer, T., Blery, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S. et al., Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 2007. 104: 3384-3389.
44. + T cells upon CD226 engagement. J. Immunol. 2005. 175: 4914-4926.
45. + lymphocytes and soluble granzyme B in bronchoalveolar lavage of allergen challenged patients with atopic asthma. Clin. Exp. Immunol. 2004. 136: 542-548.
46. Meyer, E. H., DeKruyff, R. H. and Umetsu, D. T., iNKT cells in allergic disease. Curr. Top. Microbiol. Immunol. 2007. 314: 269-291.